ABSTRA
DEAD

Serial Number

97912689

Owner

Owkin, Inc.

Attorney

Andrew D. Bochner

Filing Date

Apr 28, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ABSTRA Trademark

Serial Number: 97912689

ABSTRA is a trademark filed by Owkin, Inc. on April 28, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 38 (Telecommunications), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Owkin, Inc. (12 trademarks)

831 Broadway, Unit 3R
New York, NY 10003

Entity Type: 03

Trademark Details

Filing Date

April 28, 2023

Registration Date

Not Registered

Published for Opposition

February 11, 2025

Goods & Services

Telecommunication services, namely, transmission of voice, data, messages, videos, and documents via the Internet and telecommunications networks; digital network telecommunications services; telecommunications gateway services; Computer intercommunication, namely transmission of information via computers connected to the same network and providing telecommunications connections to a global computer network; Communications by computer terminals; Computer aided transmission of messages, information and images; Transmission of data and information by computer and electronic communication networks; Communication services, namely, electronic transmission of voice, data, messages, videos, and documents between data banks; Electronic data interchange services; Providing multiple-user access to a global computer information network; Providing multiple use access to global computer information networks for the transfer and dissemination of a wide range of information; Transmission of electronic mail; Provision of telecommunications access to databases and the internet

Downloadable and recorded databases in the field of medical data; downloadable and recorded databases in the field of medical research and development; downloadable and recorded software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; downloadable and recorded software for diagnosing medical conditions, prescribing medical treatment and prescriptions, designing clinical trials and forecasting clinical trial results, for searching for clinical trial patients, for analyzing medical images, for analyzing data, for developing pharmaceutical products and chemical compounds, for providing online databases, for processing, accessing, and inputting medical information in the field of medical research and development, and for use in fostering communication and collaboration between healthcare researchers, data scientists, and clinicians in the field of medical research and development; downloadable computer and mobile application software for diagnosing medical conditions, prescribing medical treatment and prescriptions, designing clinical trials and forecasting clinical trial results, for searching for clinical trial patients, for analyzing medical images, for analyzing data, for developing pharmaceutical products and chemical compounds, for providing online databases, for processing, accessing, and inputting medical information in the field of medical research and development, and for use in fostering communication and collaboration between healthcare researchers, data scientists, and clinicians in the field of medical research and development; downloadable and recorded artificial intelligence computer and mobile application software for diagnosing medical conditions, prescribing medical treatment and prescriptions, designing clinical trials and forecasting clinical trial results, for searching for clinical trial patients, for analyzing medical images, for analyzing data, for developing pharmaceutical products and chemical compounds, for providing online databases, for processing, accessing, and inputting medical information in the field of medical research and development, and for use in fostering communication and collaboration between healthcare researchers, data scientists, and clinicians in the field of medical research and development; downloadable and recorded software as a Medical Device (SaMD) for analyzing genome information; downloadable and recorded artificial computer and mobile application software for healthcare, namely for machine learning in the field of healthcare, for diagnosing medical conditions, prescribing medical treatment and prescriptions, designing clinical trials and forecasting clinical trial results, for searching for clinical trial patients, for analyzing medical images, for analyzing data, for developing pharmaceutical products and chemical compounds, for providing online databases, for processing, accessing, and inputting medical information in the field of medical research and development, and for use in fostering communication and collaboration between healthcare researchers, data scientists, and clinicians in the field of medical research and development; downloadable and recorded computer software for database management; Software as a Medical Device (SaMD), downloadable, for diagnosing cancer; downloadable and recorded computer software development tools; Computer software platforms, downloadable, for diagnosing medical conditions, prescribing medical treatment and prescriptions, designing clinical trials and forecasting clinical trial results, for searching for clinical trial patients, for analyzing medical images, for analyzing data, for developing pharmaceutical products and chemical compounds, for providing online databases, for processing, accessing, and inputting medical information in the field of medical research and development, for providing online databases and for use in fostering communication and collaboration between healthcare researchers, data scientists, and clinicians in the field of medical research and development; Recorded computer programs using artificial intelligence (AI) for connecting healthcare researchers and data scientists in the field of medical research and development; Downloadable electronic publications in the nature of journals, articles, case reports, technical notes, editorials, white papers, pamphlets, and blog posts in medical field; Interfaces for computers; Network servers, namely, cloud servers

Software as a service (SaaS) featuring software to diagnose medical conditions, to prescribe medical treatment and prescriptions, to design clinical trials and forecast clinical trial results, to search for clinical trial patients, to analyze medical images, to analyze data, and to develop pharmaceutical products and chemical compounds; Scientific and medical research; Technological research in the field of artificial intelligence and machine learning; Scientific and technological services, namely, scientific research in the field of design of clinical trials, data analysis, and projection of clinical trial results; Medical research; Scientific research for medical purposes

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Nov 10, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Nov 10, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 8, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 23, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 10, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 10, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 10, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 30, 2024 GNRN
NON-FINAL ACTION E-MAILED
Oct 30, 2024 GNRT
NON-FINAL ACTION WRITTEN
Oct 30, 2024 CNRT
EXAMINER'S AMENDMENT ENTERED
Oct 4, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 4, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 4, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 4, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 29, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 29, 2024 CRFA
ASSIGNED TO LIE
Aug 29, 2024 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 26, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 26, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 26, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 26, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 26, 2024 COAR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 27, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 31, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 25, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 27, 2023 NWOS
NEW APPLICATION ENTERED
May 2, 2023 NWAP